Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis

RECRUITING

Identifier: CI-TRIAL-00122852
Entity page: /trial/NCT05145816 ↗
Edges: 7

Neighbours: 2 cancers1 drugs
Drawn: 3 of 3 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis condition of …CONDITION_OFderived2 of 2
← condition of	AL Amyloidosis registry condition “AL Amyloidosis” mapped ONTOLOGY_EXACT	—	—	AL Amyloidosis	1	Observed	clinicaltrials	graph →
← condition of	Amyloidosis registry condition “Amyloidosis” mapped ONTOLOGY_EXACT	—	—

Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis intervention of …INTERVENTION_OFderived5 of 5
← intervention of	Belantamab Mafodotinadc registry intervention “Belantamab mafodotin 1.0 mg/kg (12 weeks)” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Belantamab Mafodotinadc registry intervention “Belantamab mafodotin 1.4 mg/kg (12 weeks)” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Belantamab Mafodotinadc registry intervention “Belantamab mafodotin 1.9 mg/kg (12 weeks)” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Belantamab Mafodotinadc registry intervention “Belantamab mafodotin 1.9 mg/kg (8 weeks)” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Belantamab Mafodotinadc registry intervention “Belantamab mafodotin 2.5 mg/kg (8 weeks)” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →

Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis intervention of …INTERVENTION_OFderived5 of 5

← intervention of

Belantamab Mafodotinadc

registry intervention “Belantamab mafodotin 1.0 mg/kg (12 weeks)” (DRUG) mapped ALIAS

—

not mapped

Observed

clinicaltrials

graph →

← intervention of

Belantamab Mafodotinadc

registry intervention “Belantamab mafodotin 1.4 mg/kg (12 weeks)” (DRUG) mapped ALIAS